Vitiligo has seen significant advancements in treatment approaches over recent years. This Next Steps in Derm video interview, conducted in conjunction with the Pigmentary Disorders Exchange Symposium, delves into the future of oral therapies for vitiligo and how these treatments situate within the broader spectrum of vitiligo management.

‍

In the interview, Iltefat Hamzavi, MD, FAAD, clinical associate professor of dermatology at Wayne State University School of Medicine, sets the stage with certain fundamental understandings about vitiligo that are especially important to consider when evaluating oral therapies. Time and patience are required when determining treatment success as the vitiligo improvement curve is gradual. However, Dr. Hamzavi says meaningful quality of life impact does not require full repigmentation. Targeting visible areas such as the face could vastly enhance an individual’s confidence and quality of life.

‍

As Dr. Hamzavi articulates, oral options represent a significant leap forward in managing inflammation and aiding the wound healing process essential for repigmentation. Recognizing where these treatments fit within the overall management of vitiligo is paramount.